SCHEMBL435303

SCHEMBL435303

[CH2]c1ccc(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL3583090 0.79
SCHEMBL1799996 0.75
SCHEMBL31103 0.75
SCHEMBL2391248 0.69
SCHEMBL12578009 0.67 TDP1 (0.67)
Dimethylamine SCHEMBL3189287 0.67 TDP1 (0.79)
P-Xylene SCHEMBL16684588 0.67 TDP1 (0.79)
SCHEMBL20262193 0.65 TDP1 (0.53)
SCHEMBL10064162 0.65 TDP1 (0.62)
SCHEMBL183148 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 569 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP claimed
EP-4178959-A1 NITROGEN HETEROCYCLIC CYTOKININ DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2023-05-17 EP claimed
US-11643413-B2 9-(2-oxacycloalkyl)-9H-purine-2,6-diamine derivatives and their use for the treatment of skin disorders UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2023-05-09 US claimed
CN-115403788-A Cascade enzyme catalysis crosslinking natural polysaccharide hydrogel and preparation method and application thereof 河南师范大学 2022-11-29 CN claimed
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 EP claimed
WO-2022012702-A1 NITROGEN HETEROCYCLIC CYTOKININ DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2022-01-20 WO claimed
CN-112939980-A 3, 4-dichloroisothiazole heterocyclic purine derivatives and preparation method and application thereof 南开大学 2021-06-11 CN claimed
US-20200157105-A1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-05-21 US claimed
EP-3615535-A1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS Univerzita Palackého v Olomouci (CZ) 2020-03-04 EP claimed
EP-3191482-B1 1,2,3-THIADIAZOL-5YL-UREA DERIVATIVES, USE THEREOF FOR REGULATING PLANT SENESCENCE AND PREPARATIONS CONTAINING THESE DERIVATIVES USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-03-27 EP claimed
CN-1030452-C Process for preparing 2-aminopyrimidinone derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-12-06 CN claimed
EP-0378254-B1 2-Aminopyrimidinone derivatives JANSSEN PHARMACEUTICA NV (BE) 1994-06-22 EP claimed
EP-0561535-A2 Enantiomeric enrichment of cyanohydrins BEND RESEARCH, INC. (US) 1993-09-22 EP claimed
US-5241087-A ENANTIOMERIC ENRICHMENT OF CYANOHYDRINS BEND RESEARCH, INC. (US) 1993-08-31 US claimed
US-5126339-A Antihistamine, antiserotonine JANSSEN PHARMACEUTICA N.V. (BE) 1992-06-30 US claimed
US-5025014-A Antiallergens JANSSEN PHARMACEUTICA N.V. (BE) 1991-06-18 US claimed
US-5008268-A Antiallergens JANSSEN PHARMACEUTICA N.V. (BE) 1991-04-16 US claimed
CN-1044099-A The 2-aminopyrimidinone derivatives JANSSEN PHARMACEUTICA NV (BE) 1990-07-25 CN claimed
EP-0378254-A2 2-Aminopyrimidinone derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-07-18 EP claimed
US-4888426-A CHEMICAL INTERMEDIATES JANSSEN PHARMACEUTICA N.V. (BE) 1989-12-19 US claimed